Reply to: "Both tacrolimus and mycophenylate mophetil should be considered second-line therapy for autoimmune hepatitis"
Related Research units
Bibliographical data
| Original language | English |
|---|---|
| ISSN | 0168-8278 |
| DOIs | |
| Publication status | Published - 03.2021 |
| PubMed | 33309116 |
|---|
